These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 7138283)
21. Comparison of combined statin-fibrate treatment to monotherapy in patients with mixed hyperlipidemia. Kłosiewicz-Latoszek L; Szostak WB; Grzybowska B; Białobrzeska-Paluszkiewicz J; Wiśniewska B; Stolarska I Kardiol Pol; 2004 Jun; 60(6):567-77. PubMed ID: 15334157 [TBL] [Abstract][Full Text] [Related]
22. Multivariate assessment of lipid parameters as predictors of coronary heart disease among postmenopausal women: potential implications for clinical guidelines. Shai I; Rimm EB; Hankinson SE; Curhan G; Manson JE; Rifai N; Stampfer MJ; Ma J Circulation; 2004 Nov; 110(18):2824-30. PubMed ID: 15492318 [TBL] [Abstract][Full Text] [Related]
23. A 12-week, prospective, open-label analysis of the effect of rosuvastatin on triglyceride-rich lipoprotein metabolism in patients with primary dyslipidemia. Kostapanos MS; Milionis HJ; Filippatos TD; Nakou ES; Bairaktari ET; Tselepis AD; Elisaf MS Clin Ther; 2007 Jul; 29(7):1403-14. PubMed ID: 17825691 [TBL] [Abstract][Full Text] [Related]
24. [High-density lipoproteins in children with coronary diseases]. Oberhänsli I; Pometta D; Micheli H; Raymond L Helv Paediatr Acta; 1981; 36(2):135-47. PubMed ID: 7251385 [TBL] [Abstract][Full Text] [Related]
25. [The new atherogenic plasma index reflects the triglyceride and HDL-cholesterol ratio, the lipoprotein particle size and the cholesterol esterification rate: changes during lipanor therapy]. Dobiásová M; Frohlich J Vnitr Lek; 2000 Mar; 46(3):152-6. PubMed ID: 11048517 [TBL] [Abstract][Full Text] [Related]
26. [Effects of plasma very low density lipoprotein, low density lipoprotein and high density lipoprotein on platelet aggregation in endogenous hypertriglyceridemia]. Deng Z; Liu B; Zhou J; Zhang Z; Liu Y; Bai H Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Oct; 34(4):704-7. PubMed ID: 14619587 [TBL] [Abstract][Full Text] [Related]
27. [The evaluation of lipoprotein as a screening test for coronary heart disease]. Li SC Zhonghua Liu Xing Bing Xue Za Zhi; 1989 Jun; 10(3):167-71. PubMed ID: 2776196 [TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds: a meta-analysis of randomized controlled trials. Birjmohun RS; Hutten BA; Kastelein JJ; Stroes ES J Am Coll Cardiol; 2005 Jan; 45(2):185-97. PubMed ID: 15653014 [TBL] [Abstract][Full Text] [Related]
29. [High and low density lipoprotein abnormalities in coronary patients with LDL-C at target and uncontrolled HDL-C and triglycerides]. Posadas-Romero C; Posadas-Sánchez R; Juárez-Rojas JG; Medina-Urrutia A; Jorge-Galarza E; Cardoso-Saldaña G; Caracas-Portilla N; Mendoza-Peŕez E Arch Cardiol Mex; 2008; 78(1):30-9. PubMed ID: 18581711 [TBL] [Abstract][Full Text] [Related]
30. [Distribution of lipoprotein fractions in men with arteriosclerosis obliterans]. Karádi I; Szabolcs Z; Szénási P; Hosszúfalusi N; Császár A; Kusztos R; Romics L Orv Hetil; 1989 Jul; 130(28):1489-92. PubMed ID: 2748165 [TBL] [Abstract][Full Text] [Related]
31. [Disruption of the cholesterol-transport function of lipoproteins in the blood plasma of patients with ischemic heart disease]. Gerasimova EN; Perova NV; Kurdanov KhA; Polesskiĭ VA Vopr Med Khim; 1984; 30(6):71-6. PubMed ID: 6528538 [TBL] [Abstract][Full Text] [Related]
32. The role of plasma lipids in carotid bifurcation atherosclerosis. Ford CS; Crouse JR; Howard G; Toole JF; Ball MR; Frye J Ann Neurol; 1985 Mar; 17(3):301-3. PubMed ID: 3994317 [TBL] [Abstract][Full Text] [Related]
33. Lipidemic effects of a mild-term treatment with calcium heparin in vasculopathic subjects. Ferlito S; Ossino AM; Puleo M; Puleo R; Di Mauro C Panminerva Med; 1989; 31(4):171-6. PubMed ID: 2633106 [TBL] [Abstract][Full Text] [Related]
34. [Fuenlabrada study: lipid and lipoprotein levels in children and adolescents associated with ischemic cardiopathy prevalence among their relatives]. Plaza I; Mariscal RP; Muñoz MT; Ros-Jellici J; López D; Madero R; Hidalgo I; Ceñal MJ; Baeza J; Cobaleda A Rev Esp Cardiol; 1990 Apr; 43(4):212-8. PubMed ID: 2353119 [TBL] [Abstract][Full Text] [Related]
35. The effect on HDL cholesterol of oxprenolol and atenolol. Kjeldsen SE; Eide I; Leren P; Foss OP; Holme I; Eriksen IL Scand J Clin Lab Invest; 1982 Sep; 42(5):449-53. PubMed ID: 6130595 [TBL] [Abstract][Full Text] [Related]
36. [Various lipoprotein fractions and their relation to ischemic heart disease]. Palazzuoli V; Mondillo S; Kristodhullu A; De Stefano R; Amatucci G G Ital Cardiol; 1983; 13(2):90-4. PubMed ID: 6884650 [TBL] [Abstract][Full Text] [Related]
37. The effects of menopause and training on serum lipids. Rainville S; Vaccaro P Int J Sports Med; 1984 Jun; 5(3):137-41. PubMed ID: 6746176 [TBL] [Abstract][Full Text] [Related]
38. Atherogenic lipoprotein profile in families with and without history of early myocardial infarction. Dobiásová M; Raslová K; Rauchová H; Vohnout B; Ptácková K; Frohlich J Physiol Res; 2001; 50(1):1-8. PubMed ID: 11300220 [TBL] [Abstract][Full Text] [Related]
39. [Changes in high density lipoproteins in peripheral vascular disease]. Pedro-Botet J; Sentí M; Nogués X; Rubiés-Prat J; Vidal-Barraquer F Med Clin (Barc); 1991 Apr; 96(13):493-5. PubMed ID: 2051792 [TBL] [Abstract][Full Text] [Related]
40. Inverse relationship of serum LDL cholesterol and the LDL/HDL cholesterol ratio to liver microsomal enzyme induction in man. Luoma PV; Sotaniemi EA; Pelkonen RO Res Commun Chem Pathol Pharmacol; 1983 Oct; 42(1):173-6. PubMed ID: 6648042 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]